Martin Clynes
Affiliations: | National Ins. for Cellular Biotechnology | Dublin City University, Dublin, County Dublin, Ireland |
Google:
"Martin Clynes"Collaborators
Sign in to add collaborator| Robert M. Straubinger | collaborator | 2002- | Dublin City University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| O'Neill F, Allen-Coyle TJ, Roche S, et al. (2023) Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples, Adjacent Normal Tissue, and Xenografts Derived from These Tumors. Life (Basel, Switzerland). 13 |
| Allen-Coyle TJ, Niu J, Welsch E, et al. (2022) FOLFIRINOX Pharmacodynamic Interactions in 2D and 3D Pancreatic Cancer Cell Cultures. The Aaps Journal. 24: 108 |
| Coleman O, Henry M, OʼNeill F, et al. (2020) Proteomic Analysis of Cell Lines and Primary Tumors in Pancreatic Cancer Identifies Proteins Expressed Only In Vitro and Only In Vivo. Pancreas. 49: 1109-1116 |
| Johnston MC, Nicoll JA, Redmond KM, et al. (2020) DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo models. Journal of Controlled Release : Official Journal of the Controlled Release Society |
| Roche S, O'Neill F, Murphy J, et al. (2020) Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients. International Journal of Molecular Sciences. 21 |
| Coleman O, Henry M, O'Neill F, et al. (2018) A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts. Proteomes. 6 |
| Coleman O, Henry M, McVey G, et al. (2016) Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact. Expert Review of Proteomics. 13: 383-94 |
| Walsh N, Larkin A, Swan N, et al. (2011) RNAi knockdown of Hop (Hsp70/Hsp90 organising protein) decreases invasion via MMP-2 down regulation. Cancer Letters. 306: 180-9 |
| Walsh N, O'Donovan N, Kennedy S, et al. (2009) Identification of pancreatic cancer invasion-related proteins by proteomic analysis. Proteome Science. 7: 3 |
| Maurya P, Meleady P, Dowling P, et al. (2007) Proteomic approaches for serum biomarker discovery in cancer. Anticancer Research. 27: 1247-55 |